Ligand ID: 803


Drugbank ID:
DB00227
(Lovastatin)


Indication:
For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia. For primary prevention of coronary heart disease and to slow progression of coronary atherosclerosis in patients with coronary heart disease.

Get human targets for 803 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND '803' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
LEU A 242
VAL A 202
LEU A 271
LEU A 272
1.57A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  89
VAL A  91
LEU A 177
1.64A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  77
LEU A  67
LEU A  87
LEU A  89
1.46A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
LEU A 271
TYR A 239
LEU A 242
LEU A 205
1.80A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  42
LEU A  89
VAL A  77
LEU A  27
1.62A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  86
LEU A  27
VAL A  20
LEU A  58
1.58A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A 261
LEU A 208
VAL A 212
LEU A 250
1.65A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A 202
LEU A 208
TYR A 239
LEU A 242
1.79A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  27
VAL A  42
LEU A 177
1.52A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		5 / 7
VAL C 976
LEU A 977
VAL A 976
LEU B 984
LEU B 981
1.40A28.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		5 / 10
LEU D 977
ILE D 980
LEU E 984
LEU E 981
VAL E1164
1.41A28.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6m71 NSP8
(SARS-CoV-2)		5 / 10
VAL B 186
ILE B 132
TYR B 138
LEU B 180
VAL B 167
1.33A20.10

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU C  13
VAL C  12
LEU D  98
LYS C   2
VAL C   6
1.62A20.36

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6m71 NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.32A20.36

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6vww URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
VAL A 321
ILE A 323
TYR A 194
GLU A 211
LEU A 251
1.33A21.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
TYR A 113
LEU A  93
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
TYR B 113
LEU B  93
LEU B 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL B 155
LEU B  12
VAL B 165
LEU B 126
1.41A
SO4  B 204 (-3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B  34
LEU B 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 7
VAL A 227
VAL A 126
LEU A 117
LEU A 229
1.24A9.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 7
VAL A6842
LEU A6834
VAL A6995
LEU B4298
1.77A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
LEU A6893
TYR A6845
LEU A6852
LEU A6924
1.71A20.74
None
SAM  A7104 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
LEU A6924
VAL A6865
LEU A7052
LEU A7050
1.60A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL A7086
LEU A6909
VAL A6916
LEU A6893
1.52A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL A6865
LEU A6857
VAL A6859
LEU A6883
1.36A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL A6859
LEU A6887
VAL A6865
LEU A6855
1.62A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
LEU A6887
VAL A6865
LEU A6848
LEU A6852
1.61A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.58A20.51
AMP  A 201 ( 4.4A)
AMP  A 201 ( 4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
LEU B 153
VAL B 155
LEU B 109
LEU B 127
1.43A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 155
LEU A  12
VAL A 165
LEU A 126
1.54A20.51
AMP  A 201 ( 4.4A)
None
None
AMP  A 201 ( 4.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.31A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A  93
VAL A  95
LEU A 153
1.65A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.29A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 165
LEU B 153
LEU A  10
LEU B  10
1.61A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.45A20.51
None
AMP  A 201 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B 151
TYR B 113
1.67A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B  53
VAL B  49
LEU B 122
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 165
LEU A 126
VAL A 155
LEU A  12
1.42A20.51
None
AMP  A 201 ( 4.4A)
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
VAL B  95
LEU B 140
LEU B 153
1.75A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
LEU A 127
LEU A 164
LEU A 153
1.55A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 144
LEU A 126
LEU A  10
LEU A  12
1.66A20.51
None
AMP  A 201 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
TYR B 113
LEU B  93
LEU B 122
1.39A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.28A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
LEU A 126
LEU A 127
1.51A20.51
None
None
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		5 / 10
LEU B 126
VAL B 155
ILE B  18
TYR B 161
LEU B 169
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
LEU B 127
LEU B 164
LEU B 153
1.55A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B 164
VAL B 155
LEU B 109
1.42A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.34A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 144
LEU B  10
LEU B 126
LEU B 140
1.78A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A  16
LEU A 109
1.70A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
LEU B 126
LEU B 127
1.48A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
TYR A 113
LEU A  93
LEU A 122
1.42A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 144
LEU A 126
LEU A 169
LEU A  12
1.60A20.51
None
AMP  A 201 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B  16
LEU B 109
1.73A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 144
LEU B 126
LEU B  10
LEU B  12
1.50A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 165
LEU B 153
VAL B 155
LEU A  10
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
VAL A  95
LEU A 140
LEU A 153
1.77A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B  34
LEU B 127
1.41A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B  10
LEU B 126
LEU B 140
1.79A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A  34
LEU A 127
1.41A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 165
LEU B 126
VAL B 155
LEU B  12
1.47A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 155
LEU B  12
VAL B 165
LEU B 126
1.43A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A 151
TYR A 113
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.44A20.51
None
None
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A  53
VAL A  49
LEU A 122
1.66A20.51
None
None
AMP  A 201 ( 3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 144
LEU B 126
LEU B 169
LEU B  12
1.58A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU C6924
VAL C6865
LEU C7052
LEU C7050
1.65A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL A6859
LEU A6887
VAL A6865
LEU A6855
1.63A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 10
LEU A6909
VAL A6916
LEU A6893
LEU A6892
VAL A7086
1.72A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 7
VAL C7086
LEU C6909
VAL C6916
LEU C6893
LEU C6892
1.67A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU A6924
VAL A6865
LEU A7052
LEU A7050
1.61A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 10
LEU C6909
VAL C6916
LEU C6893
LEU C6892
VAL C7086
1.65A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU A6893
TYR A6845
LEU A6852
LEU A6924
1.71A21.62
None
SAM  A7102 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 7
VAL A7086
LEU A6909
VAL A6916
LEU A6893
LEU A6892
1.73A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU C6887
VAL C6865
LEU C6848
LEU C6852
1.66A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL C6859
LEU C6887
VAL C6865
LEU C6855
1.65A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL C7092
LEU A6909
VAL A6916
LEU A6892
1.74A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL C6865
LEU C6857
VAL C6859
LEU C6883
1.35A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU A6887
VAL A6865
LEU A6848
LEU A6852
1.64A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 7
VAL C6842
LEU C6834
VAL C6995
LEU D4298
1.69A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 7
VAL A6842
LEU A6834
VAL A6995
LEU B4298
1.77A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU C6893
TYR C6845
LEU C6852
LEU C6924
1.73A21.62
None
SAM  C7105 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A 303
ILE A 300
TYR A 251
GLU A 295
LEU A 282
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 10
VAL C 303
ILE C 300
TYR C 251
GLU C 295
LEU C 282
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A  34
LEU A 127
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
TYR A 113
LEU A  93
LEU A 122
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A 155
LEU A  12
VAL A 165
LEU A 126
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		4 / 7
VAL A 351
LEU A 331
LEU A 327
LEU A 326
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		5 / 10
LEU A 330
VAL A 359
ILE A 222
TYR A 365
LEU A 373
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		5 / 10
LEU A 330
VAL A 359
ILE A 222
LEU A 373
GLU A 374
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		4 / 7
VAL A 346
LEU A 357
VAL A 355
LEU A 313
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		4 / 7
VAL A 220
LEU A 368
VAL A 359
LEU A 313
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
NSP8
(SARS-CoV-2)		4 / 7
VAL A  12
LEU A  17
LEU A  71
LEU B  91
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A  71
LEU A  60
LEU A  59
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU A  13
VAL A  12
LEU B  98
LYS A   2
VAL A   6
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A  71
LEU A  56
LEU A  59
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wiq NSP8
(SARS-CoV-2)		5 / 10
VAL B 186
ILE B 132
TYR B 138
LEU B 180
VAL B 167
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		4 / 7
LEU A  28
VAL A  22
LEU A  56
LEU A  55
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		5 / 10
LEU A  71
ILE A  68
LEU A  60
LEU A  59
VAL A  16
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL C6865
LEU C6857
VAL C6859
LEU C6883
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wkq NSP16
(SARS-CoV-2)		4 / 7
VAL C6865
LEU C6857
VAL C6859
LEU C6883
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL D 147
LEU D 127
LEU D 123
LEU D 122
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B 164
VAL B 155
LEU B 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL D  95
LEU D 122
VAL D  34
LEU D 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C  95
LEU C 122
VAL C  34
LEU C 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
LEU D 153
VAL D 155
LEU D 109
LEU D 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C 147
LEU C 127
LEU C 123
LEU C 122
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C  16
LEU C 164
VAL C 155
LEU C 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B 151
TYR B 113
LEU B  93
LEU B 122
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A  34
LEU A 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C 151
TYR C 113
LEU C  93
LEU C 122
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL D 142
LEU D 153
VAL D 151
LEU D 109
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B  34
LEU B 127
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU C  13
VAL C  12
LEU D  98
LYS C   2
VAL C   6
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU A  13
VAL A  12
LEU B  98
LYS A   2
VAL A   6
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
(SARS-CoV-2)		4 / 7
VAL A  66
LEU A  17
VAL A  22
LEU A  60
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
(SARS-CoV-2)		4 / 7
LEU A  28
VAL A  22
LEU A  56
LEU A  55
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  27
VAL A  42
LEU A 177
1.53A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  77
LEU A  67
LEU A  87
LEU A  89
1.46A16.67
None
DMS  A 402 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
LEU A 242
VAL A 202
LEU A 271
LEU A 272
1.57A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 261
LEU A 208
VAL A 212
LEU A 250
1.66A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  89
VAL A  91
LEU A 177
1.67A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 202
LEU A 208
TYR A 239
LEU A 242
1.78A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  42
LEU A  89
VAL A  77
LEU A  27
1.63A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  86
LEU A  27
VAL A  20
LEU A  58
1.58A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 7
VAL A  66
LEU A  17
VAL A  22
LEU A  60
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 10
LEU C  13
VAL C  12
LEU D  98
LYS C   2
VAL C   6
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 7
LEU A  28
VAL A  22
LEU A  56
LEU A  55
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU D 126
VAL D 155
ILE D  18
TYR D 161
LEU D 169
1.61A
None
EDO  D 208 ( 4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E  16
LEU E 164
VAL E 155
LEU E 109
1.36A
None
None
EDO  E 205 ( 4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 142
LEU E 153
VAL E 151
LEU E 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 151
TYR E 113
LEU E  93
LEU E 122
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 142
LEU D 153
VAL D 151
LEU D 109
1.31A
None
None
None
EDO  D 204 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.30A
None
EDO  A 202 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 147
LEU D 127
LEU D 123
LEU D 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 147
LEU E 127
LEU E 123
LEU E 122
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C 126
VAL C 155
ILE C  18
TYR C 161
LEU C 169
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 151
TYR D 113
LEU D  93
LEU D 122
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C 126
VAL C 155
ILE C  18
TYR C 161
LEU C 169
1.68A
APR  C 201 (-4.8A)
APR  C 201 ( 4.9A)
None
EDO  C 203 (-4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 142
LEU D 153
VAL D 151
LEU D 109
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E  95
LEU E 122
VAL E  34
LEU E 127
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 147
LEU D 127
LEU D 123
LEU D 122
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 151
TYR C 113
LEU C  93
LEU C 122
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 147
LEU C 127
LEU C 123
LEU C 122
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 151
TYR E 113
LEU E  93
LEU E 122
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU D 126
VAL D 155
ILE D  18
TYR D 161
LEU D 169
1.65A
APR  D 201 (-4.5A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.66A
APR  A 201 (-4.8A)
APR  A 201 ( 4.8A)
None
EDO  A 203 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 147
LEU E 127
LEU E 123
LEU E 122
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 142
LEU E 153
VAL E 151
LEU E 109
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B 164
VAL B 155
LEU B 109
1.40A
None
None
EDO  B 202 (-4.0A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 147
LEU C 127
LEU C 123
LEU C 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
LEU C 153
VAL C 155
LEU C 109
LEU C 127
1.41A
None
EDO  C 206 ( 4.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 165
LEU C 126
VAL C 155
LEU C  12
1.41A
None
None
EDO  C 206 ( 4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU B 126
VAL B 155
ILE B  18
TYR B 161
LEU B 169
1.64A
None
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU B 126
VAL B 155
ILE B  18
TYR B 161
GLU B 170
1.77A
None
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 151
TYR C 113
LEU C  93
LEU C 122
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C 126
VAL C 155
ILE C  18
TYR C 161
LEU C 169
1.65A
None
EDO  C 206 ( 4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7btf NSP12
(SARS-CoV-2)		4 / 7
VAL A 587
VAL A 476
LYS A 641
LEU A 575
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		7btf NSP8
(SARS-CoV-2)		5 / 10
VAL B 186
ILE B 132
TYR B 138
LEU B 180
VAL B 167
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7btf NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv1 NSP12
(SARS-CoV-2)		4 / 7
VAL A 587
VAL A 476
LYS A 641
LEU A 575
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv1 NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv1 NSP12
NSP8
(SARS-CoV-2)		4 / 7
VAL A 335
LEU B  95
LEU A 371
LEU A 366
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv2 NSP12
(SARS-CoV-2)		4 / 7
VAL A 587
VAL A 476
LYS A 641
LEU A 575
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv2 NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.27A
None